Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket

Gainers

PHAXIAM Therapeutics S.A. PHXM shares surged 46.7% to $0.64 in pre-market trading after gaining 6% on Wednesday.
Capri Holdings Limited CPRI rose 26.8% to $43.88 in pre-market trading. Tapestry TPR is nearing a deal to buy Capri Holdings, the Wall Street Journal reported.
EBET, Inc. EBET shares gained 23.5% to $0.0489 in pre-market trading after jumping over 37% on Wednesday.
AppLovin Corporation APP shares rose 22.6% to $36.06 in pre-market trading after the company reported better-than-expected second-quarter results.
Vistagen Therapeutics, Inc. VTGN rose 19.1% to $8.38 in pre-market trading. AffaMed said that its partner Vistagen Therapeutics reported positive top-line results from its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol nasal spray in adults diagnosed with social anxiety disorder.
MDxHealth SA MDXH shares gained 18.1% to $4.12 in pre-market trading after the company said Cigna has expanded commercial and Medicare Advantage coverage to include the Company’s Select mdx for Prostate Cancer test.
Avalo Therapeutics, Inc. AVTX gained 15.7% to $0.1765 in pre-market trading after falling over 8% on Wednesday.
T2 Biosystems, Inc. TTOO gained 15.3% to $0.3950 in pre-market trading after gaining over 10% on Wednesday. T2 Biosystems regained compliance with Nasdaq's market value of listed securities requirement.
AERWINS Technologies Inc. AWIN shares climbed 14.5% to $0.2599 in pre-market trading after gaining around 6% on Wednesday.
WeWork Inc. WE shares rose 10.2% to $0.1421 in pre-market trading. WeWork shares fell over 38% on Wednesday after the company reported worse-than-expected second-quarter financial results.

Losers

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.

Galera Therapeutics, Inc. GRTX fell 81.7% to $0.4094 in pre-market trading after the company received Complete Response Letter from the U.S. FDA for avasopasem manganese.
Amyris, Inc. AMRS shares fell 56.2% to $0.15 in pre-market trading after the company filed for bankruptcy in the US.
Origin Materials, Inc. ORGN fell 53.1% to $2.03 in pre-market trading after the company reported mixed second-quarter financial results.
SciSparc Ltd. SPRC shares fell 39.4% to $0.2998 in pre-market trading after the company reported a proposed underwritten public offering of approximately $1.3 million.
180 Life Sciences Corp. ATNF fell 24.9% to $0.6342 in pre-market after gaining around 12% on Wednesday.
Renovaro Biosciences Inc. RENB fell 24.4% to $1.17 in pre-market trading. Renovaro Biosciences shares jumped 82% on Wednesday after the company and AI-focused GEDi Cube announced a binding, exclusive letter of intent to merge.
Matinas BioPharma Holdings, Inc. MTNB fell 24.2% to $ 0.25 in pre-market trading after the company reported second-quarter results.
Innoviz Technologies Ltd. INVZ shares fell 17.5% to $2.59 in pre-market trading as the company priced $65 million upsized public offering of 26 million ordinary shares at $2.50 per share.
Greenwave Technology Solutions, Inc. GWAV fell 13.5% to $0.90 in pre-market trading.
Magnite, Inc. MGNI fell 13.2% to $10.71 in pre-market trading after the company reported second-quarter financial results.